EP3231418A1 — Granule formulation for oral administration
Assigned to Richter Gedeon Nyrt · Expires 2017-10-18 · 9y expired
What this patent protects
The invention relates to a granule formulation that enables cariprazine hydrochloride to be stably stored. The solution provides a granule formulation containing cariprazine hydrochloride, wherein said granule formulation contains lactose as a primary diluent.
USPTO Abstract
The invention relates to a granule formulation that enables cariprazine hydrochloride to be stably stored. The solution provides a granule formulation containing cariprazine hydrochloride, wherein said granule formulation contains lactose as a primary diluent.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.